Insider Buying: DENTSPLY SIRONA Inc. (XRAY) Insider Acquires $5,085,080.00 in Stock
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) insider Mark Thierer bought 77,000 shares of the business’s stock in a transaction on Monday, November 13th. The stock was bought at an average price of $66.04 per share, for a total transaction of $5,085,080.00. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at $67.18 on Friday. The stock has a market cap of $15,018.96, a price-to-earnings ratio of 26.05, a PEG ratio of 2.59 and a beta of 1.27. DENTSPLY SIRONA Inc. has a 52 week low of $52.53 and a 52 week high of $67.95. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.04. The firm had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $978.99 million. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.66 earnings per share. sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 2.66 EPS for the current fiscal year.
WARNING: “Insider Buying: DENTSPLY SIRONA Inc. (XRAY) Insider Acquires $5,085,080.00 in Stock” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/17/insider-buying-dentsply-sirona-inc-xray-insider-acquires-5085080-00-in-stock.html.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Commonwealth Bank of Australia raised its stake in DENTSPLY SIRONA by 19.0% during the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after buying an additional 260 shares during the last quarter. Acrospire Investment Management LLC bought a new position in DENTSPLY SIRONA during the second quarter worth $113,000. Dupont Capital Management Corp bought a new position in DENTSPLY SIRONA during the second quarter worth $116,000. Massey Quick Simon & CO. LLC bought a new position in DENTSPLY SIRONA during the third quarter worth $124,000. Finally, Korea Investment CORP raised its stake in DENTSPLY SIRONA by 139.9% during the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after buying an additional 1,251 shares during the last quarter. 94.65% of the stock is owned by institutional investors and hedge funds.
A number of analysts have weighed in on XRAY shares. BidaskClub lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Stifel Nicolaus restated a “buy” rating and issued a $66.00 target price (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Morgan Stanley raised their target price on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a research report on Thursday, August 10th. UBS AG restated a “neutral” rating and issued a $59.00 target price (down previously from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Finally, TheStreet lowered shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. DENTSPLY SIRONA has an average rating of “Hold” and a consensus price target of $67.00.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.